Biomarkers for Babies and Young Children With Ataxia Telangiectasia

NCT07709728 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2026-07-16

No results posted yet for this study

Summary

The goal of this observational study is to identify progressive changes of quantitative brain and lung imaging, serum and movement-related biomarkers reflecting disease progression in pre-symptomatic infants and very young children (0-5 yo) with a genetic diagnosis of A-T, that could be used in future early-life intervention trials.

Conditions

  • Ataxia Telangiectasia

Sponsors & Collaborators

  • University of Nottingham

    lead OTHER

Eligibility

Min Age
0 Years
Max Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2029-08-31
Completion
2029-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07709728 on ClinicalTrials.gov